“VERY STRANGE”: EBOLA OUTBREAK FOLLOWS VACCINE FUNDING

Nicolas Hulscher, MPH, questions the timing of new Ebola vaccine development efforts after noting Moderna and Oxford received funding months ago to develop injections targeting the same Ebola strain now linked to an outbreak in the Congo.